Web23 hours ago · Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company and world leader in galectin biology focused on the development of novel treatments for … WebFeb 17, 2024 · Galectin-8 is highly expressed in breast, prostate, and lung cancer tissues and elevated serum levels of galectin-8 promote cellular interactions between cancer cells and vascular endothelium . The treatment of endothelial cells with galectin-8 induces the production of several inflammatory cytokines such as IL-8, RANTES/CCL5, GRO-α, …
IJMS Free Full-Text Galectin-9 in Gastroenterological Cancer
WebNov 21, 2024 · Our meta-analysis supported the various function of different galectin subtypes in cancer prognosis, that converse to galectin-1, high levels of galectin-4 or galectin-9 predicted better OS and DFS in pancreatic cancer. The prognostic role of galectin-3 has been widely studied, but appears to be unclear and disparate between … WebApr 23, 2024 · Gal1 in bladder cancer. The first study on galectin expression in bladder cancer was published in 1999, in which Gal1 and Gal3 mRNA levels were found to be increased in primary or recurrent ... lamb beyti
Galectin-14 expression in ovarian cancer bioRxiv
WebFeb 22, 2024 · Galectins are animal lectins with specific affinity for galactosides via the conserved carbohydrate recognition domains. Increasing studies recently have identified critical roles of galectin family members in tumor progression. Abnormal expression of galectins contributes to the proliferation, metastasis, epithelial-mesenchymal … WebKeywords: galectin-3, serous epithelial ovarian cancer, Wnt/β-catenin pathway, prognosis. Introduction. Although the incidence of ovarian cancer is low, it is the most lethal tumor of the gynecologic genital tract, while serous epithelial ovarian cancer (SEOC) is the most common type of ovarian cancer. WebKeywords: galectin-3, serous epithelial ovarian cancer, Wnt/β-catenin pathway, prognosis. Introduction. Although the incidence of ovarian cancer is low, it is the most lethal tumor … jerod young